Copenhagen - Free Realtime Quote DKK
Orphazyme A/S (ORPHA.CO)
As of 4:44 PM GMT+2. Market Open.
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in DKK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Jakob F?rch Bendtsen | CEO & Director | -- | -- | 1978 |
Orphazyme A/S
Visionhouse
Lysk?r 8A
Herlev, 2730
Denmark
- Sector:?
- Healthcare
- Industry:? Biotechnology
- Full Time Employees:?
- 1
Description
Orphazyme A/S does not have significant operations. Previously, it was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was incorporated in 2009 and is based in Herlev, Denmark.
Corporate Governance
Orphazyme A/S’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
November 18, 2024 at 10:59 AM UTC
Orphazyme A/S Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
0.8880
-0.89%
9RP.F Lipigon Pharmaceuticals AB (publ)
0.0010
-16.67%
LVCLF Algorae Pharmaceuticals Limited
0.0070
0.00%
LYTIX.OL Lytix Biopharma AS
6.00
-1.64%
ACE.ST Ascelia Pharma AB (publ)
2.1850
-0.91%
FLUI.ST Fluicell AB (publ)
0.0720
-2.17%
XSPRAY.ST Xspray Pharma AB (publ)
63.20
+3.95%
XBRANE.ST Xbrane Biopharma AB (publ)
0.2200
+22.22%
HNSA.ST Hansa Biopharma AB (publ)
40.70
+0.49%
FLUO.ST FluoGuide A/S
38.55
+0.52%